Fortress Biotech, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Fortress Biotech, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Fortress Biotech, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $920K, a 5.02% increase year-over-year.
  • Fortress Biotech, Inc. annual Operating Lease, Payments for 2023 was $3.55M, a 2.19% increase from 2022.
  • Fortress Biotech, Inc. annual Operating Lease, Payments for 2022 was $3.47M, a 3.18% increase from 2021.
  • Fortress Biotech, Inc. annual Operating Lease, Payments for 2021 was $3.37M, a 13.8% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $920K +$44K +5.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $876K +$5K +0.57% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $871K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2020 $451K -$316K -41.2% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q1 2019 $767K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.